ANS is committed to advancing, fostering, and promoting the development and application of nuclear sciences and technologies to benefit society.
Explore the many uses for nuclear science and its impact on energy, the environment, healthcare, food, and more.
Explore membership for yourself or for your organization.
Conference Spotlight
2025 ANS Winter Conference & Expo
November 8–12, 2025
Washington, DC|Washington Hilton
Standards Program
The Standards Committee is responsible for the development and maintenance of voluntary consensus standards that address the design, analysis, and operation of components, systems, and facilities related to the application of nuclear science and technology. Find out What’s New, check out the Standards Store, or Get Involved today!
Latest Magazine Issues
Nov 2025
Jul 2025
Latest Journal Issues
Nuclear Science and Engineering
December 2025
Nuclear Technology
November 2025
Fusion Science and Technology
Latest News
Sellafield awards $6B ‘high hazard risk reduction’ framework contract
Sellafield Ltd., the site license company overseeing the decommissioning of the United Kingdom’s Sellafield nuclear site in Cumbria, England, has awarded a 15-year framework contract worth up to £4.6 billion ($6 billion) to support “high hazard risk reduction programs” at the site.
A. Melintescu, D. Galeriu
Fusion Science and Technology | Volume 54 | Number 1 | July 2008 | Pages 269-272
Technical Paper | Environment and Safety | doi.org/10.13182/FST08-A1810
Articles are hosted by Taylor and Francis Online.
In the frame of IAEA EMRAS (Environmental Modelling for Radiation Safety) programme, there was developed a scenario for models' testing starting with unpublished data for a sow fed with OBT for 84 days. The scenario includes model predictions for the dynamics of tritium in urine and faeces and HTO and OBT in organs at sacrifice. There have been done two inter-comparison exercises and most of the models succeeded to give predictions better than a factor 3 to 5, excepting faeces. There has been done an analysis of models' structure, performance and limits in order to be able to build a model of moderate complexity with a reliable predictive power, able to be applied for human dosimetry, also, when OBT data are missing.